German MedTech Firm Dräger Establish ODC at Tata Elxsi's Pune Facility

Tata Elxsi and Dräger, a global leader in medical and safety technology, have announced an innovative partnership to drive critical care innovation in India.

As part of this collaboration, Dräger is expanding its research and development presence by establishing a new Offshore Development Center (ODC) at Tata Elxsi's facility in Pune.

The ODC will focus on developing innovative critical care medical devices for both local and international markets. This partnership combines Tata Elxsi's design and technology expertise with Dräger's expertise in medical and safety technology.

The development center will unite talent from both organizations, dedicated to designing and developing innovative critical care medical devices for deployment in the Operation Theatre (OT) environment worldwide. The ODC provides a comprehensive critical care equipment testing facility, equipped with medical-grade gases, compressors, and oxygen cylinders to create a test environment that meets the demanding requirements of the OT setup.

This collaboration aims to push the boundaries of medical innovation, adhering to the highest safety and efficacy standards for critical care settings. It showcases Indian R&D capabilities on the global stage and marks Dräger's second R&D center in India. The partnership underscores the strategic importance of India as an R&D hub and sets new standards in critical care equipment development.

Dräger is a German company based in Lübeck that specializes in breathing and protection equipment, gas detection and analysis systems, and non-invasive patient monitoring technologies. Their products are used by hospitals, fire departments, and diving companies worldwide.

Founded in 1889, Dräger has grown into a global enterprise with over 16,000 employees and a presence in more than 190 countries. In 2023, the company generated net sales of approximately EUR 3.4 billion. Their commitment to safety and innovation makes them a significant player in critical care technology.

Tata Elxsi's Healthcare & Life Sciences practice is ISO 13485 certified and collaborates with prominent medical device and pharmaceutical OEMs, as well as technology companies. With a comprehensive services and solutions portfolio, Tata Elxsi adds value at every stage of the customer's product development lifecycle.


Post a Comment

Previous Post Next Post
Like this content? Sign up for our daily newsletter to get latest updates.